4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-025114
Chief Executive Officer sold 8,408 shares at $3.71 ($31,183)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Brainard Diana · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-19 | Sale : show line 1 in the form 10b5-1 | −8,408 | $3.71 | $31,183 | 921,164 | D |
| Open-market sales · 8,408 sh · avg $3.71 · $31,183 | ||||||
Loading xslF345X04/doc4.xml…